For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Infectious Disease Research Institute

USPTO Granted Patents = 34

CIPO Patents = 4

EPO Patents = 20

Forward Citations = 224

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Steven G Reed (29 out of 145 patents)

Darrick Carter (13 out of 57 patents)

Yasuyuki Goto (5 out of 6 patents)

4. Rhea N Coler (4 out of 12 patents)

5. Neal Van Hoeven (4 out of 8 patents)

6. Christopher B Fox (3 out of 15 patents)

7. Gregory C Ireton (3 out of 5 patents)

8. Ajay Bhatia (3 out of 18 patents)

9. Sylvie Bertholet (2 out of 4 patents)

10. Amit Praful Khandhar (2 out of 23 patents)

11. Susan S Lin (2 out of 4 patents)

12. Rima McLeod (1 out of 8 patents)

13. Kamal El Bissati (1 out of 6 patents)

14. Jesse Erasmus (1 out of 17 patents)

15. Malcolm Duthie (1 out of 17 patents)

34 patents: Sort by Forward Citations

1. 11266602 - PEGylated liposomes and methods of use (2022-03-08),

2. 11173126 - Nanoalum particles comprising a PAA sizing agent (2021-11-16),

3. 11141377 - Nanostructured lipid carriers and stable emulsions and uses thereof (2021-10-12),

4. 11135281 - West nile virus vaccine and method of use thereof (2021-10-05),

5. 11091521 - Immunogenic compositions comprisingpolypeptides and fusions thereof (2021-08-17),

6. 10940198 - Herpes zoster vaccine composition (2021-03-09),

7. 10792359 - Methods of using a vaccine composition containing synthetic adjuvant (2020-10-06),

8. 10765736 - Vaccine composition containing synthetic adjuvant (2020-09-08),

9. 10632191 - Synthetic glucopyranosyl lipid adjuvants (2020-04-28),

10. 9987355 - Vaccine composition containing synthetic adjuvant (2018-06-05),

11. 9950063 - Vaccine composition containing synthetic adjuvant (2018-04-24),

12. 9909114 - [object Object] (2018-03-06),

13. 9907845 - Methods of using a vaccine composition containing synthetic adjuvant (2018-03-06),

14. 9822152 - [object Object] (2017-11-21),

15. 9814772 - Synthetic glucopyranosyl lipid adjuvants (2017-11-14),

Infectious Disease Research Institute (IDRI) is a non-profit research organization dedicated to developing products to prevent, detect, and treat infectious diseases. IDRI collaborates with partners to advance scientific understanding and develop innovative solutions that benefit global health. With a focus on neglected diseases, IDRI's research spans therapeutics, vaccines, and diagnostics, with the aim of addressing the world's most challenging infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

34 Patents

#60 in Seattle, WA

#196 in Washington

#9,680 in US

#19,060 in the World

Seattle, WA, United States of America

Infectious Disease Research Institute

Forward Citations = 224

40 inventors:

Steven G Reed (29 out of 145 patents)

Darrick Carter (13 out of 57 patents)

Yasuyuki Goto (5 out of 6 patents)

4. Rhea N Coler (4 out of 12 patents)

5. Neal Van Hoeven (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…